Amedisys (AMED) Upgraded to Sell by BidaskClub
Amedisys (NASDAQ:AMED) was upgraded by equities researchers at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Wednesday.
A number of other equities analysts have also recently weighed in on the stock. Royal Bank of Canada reissued a “hold” rating on shares of Amedisys in a research report on Monday, October 23rd. Robert W. Baird lifted their price target on shares of Amedisys from $50.00 to $60.00 and gave the stock a “neutral” rating in a research report on Friday, November 10th. Jefferies Group reissued a “buy” rating and set a $60.00 price target on shares of Amedisys in a research report on Thursday, October 12th. SunTrust Banks reissued a “buy” rating and set a $70.00 price target on shares of Amedisys in a research report on Friday, November 10th. Finally, William Blair reissued an “outperform” rating on shares of Amedisys in a research report on Tuesday, November 21st. One analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. Amedisys currently has an average rating of “Hold” and a consensus target price of $60.64.
Amedisys (NASDAQ:AMED) opened at $55.24 on Wednesday. The firm has a market cap of $1,905.89, a price-to-earnings ratio of 26.87, a PEG ratio of 1.17 and a beta of 0.73. Amedisys has a 52-week low of $45.32 and a 52-week high of $65.91. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.16.
WARNING: “Amedisys (AMED) Upgraded to Sell by BidaskClub” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece on another domain, it was stolen and reposted in violation of United States & international copyright & trademark laws. The original version of this piece can be accessed at https://www.dailypolitical.com/2018/02/09/amedisys-amed-upgraded-to-sell-by-bidaskclub.html.
Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.
Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.